SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Federica Esposito, Melissa Sorosina, Linda Ottoboni, Elaine T. Lim, Joseph M. Replogle, Towfique Raj, Paola Brambilla, Giuseppe Liberatore, Clara Guaschino, Marzia Romeo, Thomas Pertel, James M. Stankiewicz, Vittorio Martinelli, Mariaemma Rodegher, Howard L. Weiner, David Brassat, Christophe Benoist, Nikolaos A. Patsopoulos, Giancarlo Comi, Wassim Elyaman, Filippo Martinelli Boneschi, Philip L. De Jager, A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity, Annals of Neurology, 2015, 78, 1
  2. 2
    M. Romeo, V. Martinelli, M. Rodegher, E. Perego, S. Maida, M. P. Sormani, G. Comi, Validation of 1-year predictive score of long-term response to interferon-β in everyday clinical practice multiple sclerosis patients, European Journal of Neurology, 2015, 22, 6
  3. 3
    C.R.N. Polachini, R.M. Spanevello, E.A. Casali, D. Zanini, L.B. Pereira, C.C. Martins, J. Baldissareli, A.M. Cardoso, M.F. Duarte, P. da Costa, A.L.C. Prado, M.R.C. Schetinger, V.M. Morsch, Alterations in the cholinesterase and adenosine deaminase activities and inflammation biomarker levels in patients with multiple sclerosis, Neuroscience, 2014, 266, 266

    CrossRef

  4. 4
    A. H. V. Schapira, Recent advances in neurology 2013–2014, European Journal of Neurology, 2014, 21, 12
  5. 5
    Maria Pia Sormani, Nicola De Stefano, Defining and scoring response to IFN-β in multiple sclerosis, Nature Reviews Neurology, 2013, 9, 9, 504

    CrossRef